Sigachi Industries Ltd (NSE: SIGACHI) Q3 2026 Earnings Call dated Feb. 14, 2026
Corporate Participants:
Amit Raj Sinha — Managing Director & Chief Executive Officer
O. Subbarami Reddy — Chief Financial Officer
Analysts:
Ms. Hrdhi Shah — Analyst
Suruchi — Analyst
Dipesh Sancheti — Analyst
Van Solanki — Analyst
Piyush — Analyst
Sheikh Mojib Ahmed — Analyst
Shreya — Analyst
Rishikesh — Analyst
Presentation:
operator
Ladies and gentlemen, good day and welcome to the Sigaji Industries Limited Q3 and 9 months FY26 earnings conference call. As a reminder, all participant lines will be in the listen only mode and there will be an opportunity for you to ask questions after the presentation concludes.
Should you need assistance during the conference call, please signal an operator by pressing star then zero on your touchdown phone. Please note that this conference is being recorded. I now hand the conference over to Ms. Hridhi Shah from Go India Advisors. Thank you. And over to you ma’. Am.
Ms. Hrdhi Shah — Analyst
Thank you. Good afternoon everyone. It’s my pleasure to welcome you on behalf of Sigachi Industries Limited. Thank you for joining us today for quarter three and nine months FY26 earnings call. We have on the call Mr. Amitraj Sinha, Managing Director and Chief Executive Officer. Mr. O.S. reddy, Chief Financial Officer and Mr. Vivek Kumar, Company Secretary. Secretary and Compliance Officer. Please note that the today’s discussion may include certain forward looking statements and therefore they must be viewed in conjunction with the risk that the company faces. May I now request Mr. Amitrad Sinha to take us to the company’s business outlook and performance subsequently to which we will open the floor for Q and A.
Thank you. And over to you sir.
Amit Raj Sinha — Managing Director & Chief Executive Officer
Thank you. Riddhi. Good afternoon everyone. Welcome to the Q3FY26 earnings conference call of Sigachi Industries Limited. The financial results and the investor presentation have been uploaded on the stock exchanges. I hope everyone has had an opportunity to review them. Before I move into the quarter’s operational and strategic update I would like to reiterate that the past few months have been a period of reflection, learning and action for the organization. In Q2 we had committed to rebuilding Sigachi with stronger systems, deeper accountability and long term resilience. And in Q3 we have followed through on these commitments with focus on EHS systems.
Reinforcing daily operating discipline, establishing clear oversight and accountability across our manufacturing footprint. This work is ongoing and it will remain a non negotiable priority for us. Sigachi has taken all necessary measures to ensure continuity in its operation and daily activities. Our teams have continued to run organization with discipline transparency and stability, ensuring that customer commitments and business routine remains firmly on track. During the quarter we also continue to engage with industry and academic forums focused on quality and compliance, including the National CGMP Day conducted by the center for CGMP at Mahe Manipal which aligns well with our priority of strengthening manufacturing and quality systems.
From an operational standpoint, our plants are running at plant capacity, supply chains remain stable and customer demand continue to be strong. Today our current cellulose based excipient capacity stands at around 18,000 metric tonne per annum with exports accounting for nearly 62% of production. Alongside operational stability, our focus on building a safer and more responsible organization remains central and we continue to extend our support to affected families while strengthening internal systems across the company. On the growth front, our capacity expansion plans continue to Progress steadily. The 12,000 metric tons per annum MCC Dahedge capacity expansion remains on track and once commissioned our total cellulose based excipient capacity is to touch 30,000 metric tons per annum with a commissioning target of U3FY27.
In parallel, our 1,800 tonnes CCS disintegrate facility at the Hajj SEZ is also progressing well and is expected to be commissioned in the Same timeline of Q3 FY27. Supporting our portfolio and diversifying into high value XCPNs. On the API side we continue to strengthen our regulated market readiness through RD and compliance led initiatives while our O and M vertical remains steady contributor and continues to evolve as a scalable services platform aligned with long term growth priorities. As I conclude, I would like to reiterate that our operation remains stable and well managed and our ongoing projects continue to progress in line with plan.
The action we have taken over the past few quarters have reinforced the resilience of our business and ensured that our long term directions remain firmly on course. Looking ahead, we remain confident in our ability to deliver consistent and sustainable growth over the next two to three years and of course beyond that our excipient portfolio. Expanding API initiatives and the O and M services business vertical together provide a diversified and balanced growth platform with clear demand visibility and disciplined execution. We believe these businesses are well positioned to support steady value creation over the coming years. Our strategic priorities remain unchanged, expanding capacity, strengthening our product mix and improving profitability through operational excellence.
Continued investment in quality systems, safety, compliance, R and D and infrastructure will remain central to this journey, ensuring that the growth is not only scalable but but also responsible and durable. The recent period has tested the organization in many ways but it has also reaffirmed the strength of our teams. We responded with speed and responsibility, prioritized safety and business continuity, and maintained momentum on our strategic initiatives. I would like to sincerely thank our employees, partners and shareholders for their continued trust and support. As we move forward, our focus remains firmly on safety, disciplined execution and long term sustainable growth.
With a clear roadmap and a committed team, we believe Sidachi is well positioned to emerge stronger and more resilient in the periods ahead. With that, I now invite CFO Mr. Os Reddy to take you through the financials and Operational highlights for Q3FY26. Thank you.
O. Subbarami Reddy — Chief Financial Officer
Thank you sir. Good evening everyone. During Q3FY26, Sugaji reported total operating income of Rs.117.2 crores. The EBITDA for the quarter stood at Rs.5.7 crores with a margin of 4.6%. Net loss came in at rupees 0.02 crores translating to a PAT margin of 0.01% negative. The MCC segment contributed Rs.61.72 crores while the OM and API segments recorded revenues of rupees 13.35 crores and rupees 14.13 crores respectively. That concludes my update. Now we can open the floor for questions. Thank you.
Questions and Answers:
operator
Thank you very much. We will now begin the question and answer session. Anyone who wishes to ask a question may press star and one on the Touchstone telephone. If you wish to remove yourself from the question queue, you may press star and 2. Participants are requested to use handsets while asking a question. In order to ensure that the management is able to address questions from all the participants in the conference call, please limit your questions to three per participant. Ladies and gentlemen, we will wait for a moment while the question queue assembles. The first question is from the line of Suruchi from NX Wealth.
Please go ahead.
Suruchi
Hello, Am I audible?
O. Subbarami Reddy
Yes, yes audible please.
Suruchi
Yeah, this is Fuse this site. Just want to know whatever the sales we are generating earlier we used to do in the range of 20% or plus something. So is there anything related to a fire or plant earlier even what happened? Is there any bearing of those events on the margin or any additional cost here? Or do we see there is some competition, impact or pricing challenges because of which vector has gone into around 5% or something?
O. Subbarami Reddy
Yeah, yeah exactly. This is consequent to the fire accident that carrying in third quarter. Also because the all Hyderabad unit overheads are spread across the other units that is one thing. And also the material transportation cost from Hyderabad unit there is a lot of raw material was available and this has been moved to the Dahej and Jagadia units. There is an involvement of the transportation cost and the landing cost of the material increase. Thereby the raw material consumption also it is increased. And also the custom duty. Normally when we import the wood pulp we import the material against advance licensing here because the facility is not there. We had to take the goods by. Paying custom duties that is also impacted that finally that is moved to the. Other units because of that there is lower EBITDA is there in the third. Quarter and these are the main reasons.
Suruchi
Custom duty is transient or it is a permanent impact.
O. Subbarami Reddy
That is anyway we have taken transit only this is transit because already the material has come in and the wood pulp ordering is almost six months ahead. We’ll plan, we’ll plan accordingly. Material came in and this is only this transit only next that will not be there because we don’t import any material for this facility whatever run less. The facility is ready. That’s why there would not be any unforcing this.
Suruchi
So what is the future future visibility where the earning picks up and the revenue picks up and the margin also comes back to the existing level because last 2/4, 3/4 even the last quarter we had done some 7% order beta but today the. Today this quarter the EBITDA even gone down to below 5%.
O. Subbarami Reddy
Yes, yes. Because this is the material moved from the Hyderabad unit to the other units.
Suruchi
Correct. So when we. When we will come back to normalcy.
O. Subbarami Reddy
Normalcy. Maybe after fourth quarter it would be better and then gradually maybe in first. Second quarter of the next year it comes to. We expect that it comes to now and. And even fourth quarter it would be better.
Suruchi
This is the size of the CAPEX addition we are doing in total CAPEX size.
O. Subbarami Reddy
Capex size 12,000 metric tons. We are coming with MCC expansion in at the hedge facility. Whats are going on and.
Suruchi
But do we see demand in the mcc? Because our MCC revenue percentage share is going down in current quarter Also this MCCR is going down from 83% to 70%.
O. Subbarami Reddy
Yeah, that is because the production is. Not there, supply is not there. That is demand is there.
Suruchi
So we. We don’t see any challenges in the demand and the pricing erosion, correct? Not.
O. Subbarami Reddy
Not at all. Not at all. Pricing also it is increasing and then demand is there and only this is because of the last year.
Suruchi
Can you share the gross margin of last year then now currently what is the gross margin?
O. Subbarami Reddy
You are making gross margin this year it has gone up overall around 50. Plus some 6, 7% increase is there for last year. 7% increase.
Suruchi
This quarter gross margin has increased by 7%. You are saying?
O. Subbarami Reddy
Not gross margin. Raw material cost increased. Sorry. Gross margin reduced.
Suruchi
Okay, 6, 7%. So what is our steady state gross margin?
operator
Sorry to interrupt, sir, but can you please rejoin the question queue?
O. Subbarami Reddy
Yeah, sure.
Suruchi
This slide.
operator
Thank you. The next question is from the line of Dipesh Sancheti from Manya Finance. Please go ahead.
Dipesh Sancheti
Yeah. Hi. Am I audible?
O. Subbarami Reddy
Yes, audible. Please go ahead.
Dipesh Sancheti
Yeah. Okay.
O. Subbarami Reddy
In the light of the volume impact.
Dipesh Sancheti
Following the incident in Hyderabad, is there any revision on the company’s guidance in terms of revenues and margins for FY27 and FY28?
O. Subbarami Reddy
FY27, 28. Those it will go as it was earlier. Because now the transition period is going on. And then because of that the internal. Audits and safety terms redefining those things are going on. Because of that there is a production slowdown also is there? In the existing units. Otherwise that will be very steady. And then like 2728 it will be. As like before it was there. The same thing would continue from FY27 itself.
Dipesh Sancheti
I mean the whole of FY 2027.
O. Subbarami Reddy
We are expecting 27 the additional capacities. We are expecting. Once those additional capacities comes, everything would be normalized. Because the production, the revenue also it. Has reduced because of the cyber. Then the overheads to be distributed within the available units. That is one thing. And then when the new capacities comes. In, then it will absorb the overheads. Overall overheads.
Dipesh Sancheti
Right now.
O. Subbarami Reddy
We have 18,000. 18,000 metric tons. Is the capacity at the hedge around 9,882 metric tons. And Jagadhya it is 8,118. Total 18,000 metric tons capacity is there. And going Forward that another 12,000 metric. Tons will be added. Total 30,000 will be there.
Dipesh Sancheti
Metric turn it is going at full capacity utilization.
O. Subbarami Reddy
It is around. It is around 70 to 73%. It’s there. Yeah. In this quarter ending slowly, going forward. It is increasing. Because this is this transitional problems. There is a little slowdown, is there. It picks up. There is a good demand is there for MCC. Only now, right now the production constraints. Production is not there. That is the thing. There is a lower side, is there?
Dipesh Sancheti
Okay, so could you provide segment wise margin for API O and M and MCC and for your outlook for FY27?
O. Subbarami Reddy
Yeah, segment wise margin, sir, in MCC this is a transitional period. But right now this this is on. Lower side is there. And Y M it is consistently it. Is giving around 22% gross margin and API is around 10%. Other thing also around 15%. Is there MCC? As of now it is gross margins are around. We can say 40% gross margin. Is there the net margin this in O and M that is nothing but PBT or EBITDA only whatever. Except this manpower cost. There will not be any major additional cost is there in O and that is net profit or EBITDA. We can take that 22% and whereas. In MCC right now we have seen. Around 5% around 5% radius there in EBITA. And this will go up to in normal this thing once it is resumed to normal, see then it will be about 20%.
Dipesh Sancheti
Okay. And even for API you expect FY27.
operator
I’ll interrupt you Mr. Dipesh, but can you please rejoin the queue?
Dipesh Sancheti
Sure.
operator
Thank you. A reminder to all participants. Anyone who wishes to ask a question may press star and one on the attachment. The next question is from the line of Van Solanki from RSPN Ventures. Please go ahead.
Van Solanki
Hi, good afternoon management. My question is on the legal proceedings of the MDN CEO Amitra Sinha that he is just released. So is there any additional proceedings is going on? Like there can be a chances that the again the legal proceeding can start. Then we can face a issue. Is the managerial side anything?
O. Subbarami Reddy
But as of now there is no this thing. We can. We. We don’t see any question of any other proceedings. Normally it takes the case, but maybe. Maybe one year or one and a half year or so it can run. But there is no question of arrest.
Amit Raj Sinha
We can see the matter is subdued. So at this moment it will be challenging to speak anything further on this. I’m sure you understand that.
operator
Okay, interrupt you Mr. Solanki, but can you please ask business related questions?
Van Solanki
Okay. Yeah, yeah. And you just told that the 2373-74 utilization. But like what is the total number of MCC revenue? It’s around 82 crores from this quarter, right? From MCC?
O. Subbarami Reddy
Yeah. Yes. Total 117 is there on consolidated basis. Around 80 plus is there from the MCC. But this is because during this transition there are many audits. Internal audits and external audits. And the safety measurements, safety audits, those things are took place in the units. That is the reason production there was a slowdown. It picks up in Q4 and thereafter.
Van Solanki
Okay, what is MCC volumes for this quarter?
O. Subbarami Reddy
MCC volume?
Van Solanki
Yeah.
O. Subbarami Reddy
In this quarter?
Van Solanki
Yes.
O. Subbarami Reddy
Yeah. This is for the nine months around 10,000 metric tons. Is there.
Van Solanki
Okay. And.
O. Subbarami Reddy
This 9 months capacity. If you see this Full year it is 18,000 metric tons. For nine months it would be around 13,500 metric tons.
Amit Raj Sinha
Okay.
Van Solanki
Yeah. And also there is no change in the average realization price per kilogram. Right. Like because of the economic scenario and the macro economic scenario between India, US and all. Is there any change in the average realization price of MCC or CSS or API? Anything?
O. Subbarami Reddy
Yeah, nothing. There is no negative impact even a little increase only is there? But there is no negative impact on the pricing.
Van Solanki
And just one last question that Are we trading some line of thing in the CCS or API in this quarter?
O. Subbarami Reddy
Yeah, ccs it is not a trading. But see our customers they are asking along with the MCC they are asking us to supply CCS also. And in this process we used to get it some pre CCS N minus one kind of thing. And one process we do at our facility. And then we export the same thing. But not from the scratch. One process N minus one stage we. Buy and then we process and sell it in the market. Right now we are setting up of the CCS facility also our own. Because of that the customers are demanding for the ccs.
Van Solanki
Okay, thank you. That’s from my side. And all the best for the future.
O. Subbarami Reddy
Thank you. Thank you sir.
operator
Thank you. The next question is on the line of Piyush from NX Wealth. Please go ahead.
Piyush
Yeah, thank you again for the opportunity. On this promoter shareholding and on flight side is this. Our shareholding has reduced in last two quarters because of the invocation of pledge or because of the stock movement. There could be further possibility of sorry shareholding decline.
O. Subbarami Reddy
We see there would not be any further. But. But that is the invocation. Because of the invocation only. But as of now around 3.77 crores shares worth pledged. That is in overall if you see. Around 10% less than 10% out of the total share capital is 38.2 crores. NH that 3.77 crores are in the. Pledge less than 10%. And if you see among only in. The promoter shareholding that is around 25 6%.
Piyush
But we don’t.
O. Subbarami Reddy
Yes. Further this thing invocation.
Amit Raj Sinha
Okay.
Piyush
And the last question on this key by when this Hyderabad issue plant issue resolved and we become a normalcy operation. And we expect a bit of 20.
O. Subbarami Reddy
Plus that anyway once the additional expanded capacities comes in the h. The bigger facility. But Hyderabad facility that is a very small facility only two acres by when that. Yeah, this is in another 12 months. We are expecting this the H12003.
Piyush
Okay, so what is our 2027 guidance?
O. Subbarami Reddy
Because I. I don’t know the earlier guidance. Yeah. Right now earlier it was growing around 25% growth rate because of this incident. It is now it is in slow down. And FY27 also full year the capacities also it comes. It takes now we are in 2627 another one year it will take maybe last quarter few months would be the. Production we can generate from the expanded capacities. And FY28 onwards we can see it. Will resume the normality. Before earlier it was there even 27 also we can expect some. But right now we cannot comment much on that.
Piyush
And margin margin Widen margin guidance FY28.
O. Subbarami Reddy
Onwards that would be good. 27 now partially that will be a momentum.
Piyush
Will we achieve double digit ebitda?
O. Subbarami Reddy
Yeah, double. We are expecting double double digit days.
Amit Raj Sinha
Okay.
Piyush
Thank you. All the best.
O. Subbarami Reddy
Thank you. Thank you.
operator
Thank you. The next question is from the line of Sheikh Mojib Ahmed from SM Capital. Please go ahead.
Sheikh Mojib Ahmed
Hello.
O. Subbarami Reddy
Hello. Yeah please. Hello, can you hear me?
Sheikh Mojib Ahmed
Yes, please. Sir, one question. I have when this Hyderabad plant will be reopened.
O. Subbarami Reddy
That that is a small facility area, only two acres that we have not taken any addition on that. But it takes little time because that. Is not a big land is available. Moreover it is. It has come into the city limits now the government has given a notification that the the land in that area can convert into even residential or commercial space. And moreover if you even construct now also how long the CFO would be. In live consent for operation. But that’s why we are not taking any addition. But Mr. Ahmed.
Amit Raj Sinha
Yeah. I would just say that you know that Hyderabad facility was housing a 6,000 metric tons per annum facility of MCC. Current expansion at DAHI JCZ is building up a 12,000 metric tons per annum facility. So that’s nearly double the capacity. So I would say that at this moment our focus is not really to ramp up the Hyderabad facility. Because you know there are legal angles to it. Our focus is to look at the DHEZ facility as to how fast the Capex cycles turn around and we are able to commission the whole plant and then ramp it up to full capacities.
Okay.
Sheikh Mojib Ahmed
Now so as a investor should we understand in such a way that the Hyderabad plant you are not at all taking into picture. All the raw materials from there have.
O. Subbarami Reddy
Been shifted to the edge. Yes. Okay.
Amit Raj Sinha
Okay.
Sheikh Mojib Ahmed
That means the pressure of the raw material which has been shifted from Hyderabad.
O. Subbarami Reddy
To other two plants.
Sheikh Mojib Ahmed
Is that going to be continued further?
O. Subbarami Reddy
So already it has come and then now already this thing thereafter whatever the material is coming to Hyderabad directly we. Are taking it to beh in Jagadia in Gujarat. No further material is coming to Hyderabad. Unless there is a clarity right now, we are not taking any for the Hyderabad. We are not buying.
Amit Raj Sinha
Okay? Okay.
Ms. Hrdhi Shah
Okay.
O. Subbarami Reddy
Thank you.
Amit Raj Sinha
Thank you very much.
O. Subbarami Reddy
Thank you.
operator
Thank you. A reminder to all participants. Anyone who wishes to ask a question may press star N1 on the touch tone telephone. The next question is from the line of Shreya, an individual investor. Please go ahead. Hello.
Shreya
Hi, can you hear me?
O. Subbarami Reddy
Yes. Please.
Shreya
Could you elaborate on the strategic objectives and development roadmap for the new R and D facility in Hyderabad? And also has There been any CEP filings this quarter? And what are the CEP target targets for FY26 and FY27? And with respect to the Cystic Fibrosis API, what revenue contribution do you anticipate during the initial phase of the commercialization, particularly in the first half following the commencement? Please. Thank you.
Amit Raj Sinha
So shreya, for the API R&D at Hyderabad, our initial focus was to have six CEP filings from the data and the content generated of the API facility. Now when we look back at our earlier CEP filings, before the API RND came in, we had already put in six other CEP filings. So we are trying to kind of establish and see because some of the CEP filings have had some kind of queries. So working on building up on the data and content of those queries. So. So at this moment metformin is the CEP which we have got approval done around 2 quarters back.
And there are other CEPs which are in the process as. And when the CEP approval comes in, we will of course intimate the exchange. Now in terms of this translating to sales, you know, as the CEP approval comes in, we will be seeding molecules to our customers and then they will be taking their particular sales finished product and putting it into stability. So at this moment it’s difficult to quantify as to which CEP will amplify and will contribute to what magnitude of sales.
Shreya
Okay. Okay, great. Thank you. Thank you so much.
Amit Raj Sinha
Thanks.
operator
Thank you. The next question is from the line of Deepesh Sancheti from Manya Finance. Please go ahead.
Dipesh Sancheti
Yeah, just wanted to understand what is the update on the insurance which was supposed to be received from. For the Hyderabad.
O. Subbarami Reddy
Yeah, insurance. There are a few documents to be submitted. One is from the inspector of factories. The other one is fire brigade attendance. These things are pending the next week. We are submitting those documents and before. 31St March we are expecting some hada. Come out and post 31st March the final claim may. May be received.
Dipesh Sancheti
So how much is.
O. Subbarami Reddy
So what is the total total insurance towards the fixed assets? Around 48 crores and then around 4 crores of the inventory is there. And apart from this there is a. Business interruption loss BI loss of profit for a period of 12 months. That is around 25 crores. It is there. We expected in total around nearly 70 crores. But business interruption policy after 12 months only that can be considered because the. Policy period is coverage period is 12 months. And now we are expecting some ad hoc amount. Maybe around 20 to 25 crores. And then later on the fixed assets. And inventory will be settled and thereafter. The BI policy business interruption policy would be settled.
Shreya
So once this entire amount has been realized, do we expect that the promoters will again get, you know get their shareholding up? Is there any possibility.
O. Subbarami Reddy
Even. Yes, there is. This promoters intended to increase their shareholding Always. That is there.
Amit Raj Sinha
Okay.
Shreya
I mean is. Are we looking at any increase of this in this quarter or maybe in the next quarters?
O. Subbarami Reddy
Few quarters coming in going forward? Maybe a few quarters coming or. Yeah.
Shreya
Okay.
O. Subbarami Reddy
Yeah.
Shreya
Just one question on this. The company had guided for around 250 crores of revenue from Cystic Fibrosis API.
O. Subbarami Reddy
That is. That is after 12 months. Yeah, after 12 months there is because that is in R D that product has been. That is development took place and then now that is post development. Then there is a possibility to get this revenue 250 crores. After 12 months that will be commercialized and then there is a expectation.
Shreya
Okay. And how confident. How confident is the company in secure formulator or commercial partner for its API?
O. Subbarami Reddy
Yeah. Company is very pretty confident and expecting that the margins and the based upon the R D findings then we are hoping that will come into operations and then we’ll secure that revenue also. Yes.
Shreya
So who are the other key players operating within this therapy segment?
O. Subbarami Reddy
Yeah, because this is a new. This thing not known exactly. But our already team they have developed this and it is fine tuning the other aspects in this drug.
Shreya
So there is no other key player who listed on listed.
O. Subbarami Reddy
Yeah, yeah. Would be there. But so far there is no announcement because since we are enlisted after reaching some milestone, we have to announce because this is a price sensitive information. That’s why we had announced.
Amit Raj Sinha
Okay. Okay.
Shreya
Thank you so much.
O. Subbarami Reddy
Thank you. Thank you Mr. Dipesh.
operator
Thank you. A reminder to all participants. Anyone who wishes to ask a question may press star and one on the touchstone telephone. The next question Is from the line of Rishikesh from RB Investments. Please go ahead.
Rishikesh
Thanks for the opportunity. And I wanted to understand what exactly is the net debt amount right now into the balance sheet and also would like to understand the trajectory of the net debt going forward in the year FY27. How does the company look at having a particular net debt number throughout the year and current net debt number?
O. Subbarami Reddy
Yes, thank you Rishikesh. Actually as of now there is no. Long term debt outstanding in the books and the total the debt, whatever it is there that is only working capital. Is there and going forward for the. Completion of the capex and all if it is required, either we rise equity or debt but based upon the situation.
Rishikesh
And then requirement as of now there.
O. Subbarami Reddy
Is no long term debt in the books except working capital.
Rishikesh
But going forward you expect to raise more equity and for the capital purposes?
O. Subbarami Reddy
Yeah. Either some for the capex, either equity. Or debt that is not yet decided that our board will decide.
Rishikesh
And this will be particularly for the DH facility?
O. Subbarami Reddy
Yeah, the H and further cap access. Based upon when once the board takes. Addition then we’ll come up with an announcement.
Rishikesh
Any ballpark figure that you have in mind that the the overall equity plus debt raise that you are expecting to.
O. Subbarami Reddy
Do right now anyway. At the appropriate time we’ll come with an announcement. But there is a capex is there? CAPEX requirement is there. And regarding the H facility and CCS facility also is there.
Rishikesh
All right, good. Look forward to know that number. Thanks a lot.
O. Subbarami Reddy
Please. Thank you.
operator
Thank you. A reminder to all participants. Anyone who wishes to ask a question may press star and one on their Touchstone telephone. I repeat, a reminder to all participants. Anyone who wishes to ask a question may press star N1 on the Touchstone telephone. Ladies and gentlemen, that was the last question for today. I now hand the conference over to the management for closing comments. Over to you, sir.
Amit Raj Sinha
As we close today’s call, our focus. Remains on strengthening operations, advancing our expansion projects and moving forward on our journey towards becoming a fully integrated pharmaceutical company. With focus and disciplined execution, we are confident of creating sustained value for all the stakeholders. Thank you for joining us and we look forward to interacting with you again next quarter. Thank you. Thank you.
operator
Thank you. On behalf of Go India Advisors. That concludes this conference. Thank you for joining us and you may now disconnect your lines. Thank you.